title: First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
authors.affiliation: Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands. Electronic address: j.vanderschaft-5@umcutrecht.nl.
authors.forename: Jorien
authors.initials: J
authors.lastname: van der Schaft
authors.affiliation: Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, The Netherlands; Department of Clinical Chemistry, Erasmus University Medical Center Rotterdam, The Netherlands.
authors.forename: Ron H N
authors.initials: RH
authors.lastname: van Schaik
authors.affiliation: Department of Nephrology and Hypertension, University Medical Center Utrecht, The Netherlands.
authors.forename: Arjan D
authors.initials: AD
authors.lastname: van Zuilen
authors.affiliation: Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands.
authors.forename: Dirk-Jan
authors.initials: DJ
authors.lastname: Hijnen
authors.affiliation: Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, The Netherlands.
authors.forename: Maarten Ten
authors.initials: MT
authors.lastname: Berg
authors.affiliation: Department of Clinical Pharmacy, University Medical Center Utrecht, The Netherlands.
authors.forename: Marcel P H
authors.initials: MP
authors.lastname: van den Broek
authors.affiliation: Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands.
authors.forename: Carla A F M
authors.initials: CA
authors.lastname: Bruijnzeel-Koomen
authors.affiliation: Department of Dermatology and Allergology, University Medical Center Utrecht, The Netherlands.
authors.forename: Marjolein S
authors.initials: MS
authors.lastname: de Bruin-Weller
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D065095:Calcineurin Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D003876:Dermatitis, Atopic / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D065095:Calcineurin Inhibitors; D003692:Delayed-Action Preparations; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus